Endo International (NASDAQ:ENDP) Has Target Of $13 Give by Equity Analysts at B. Riley FBR. Buy Didn’t change.

June 29, 2018 - By Estela Ashley

Endo International plc (NASDAQ:ENDP) Corporate Logo

Big Money Sentiment decreased to 1.07 in 2018 Q1. It has change of 0.06, from 2017Q4’s 1.13. The ratio dived due to Endo International plc positioning: 25 sold and 70 reduced. 33 funds acquired holdings and 69 increased holdings. Investors holded 203.77 million in 2017Q4 but now own 213.17 million shares or 4.61% more.

Financial Architects accumulated 0% or 2,000 shs. State Common Retirement Fund holds 0% or 565,114 shs in its capital. Panagora Asset Mngmt reported 9,409 shs or 0% of all its holdings. Riverhead Cap Limited Liability Corp holds 0.01% or 41,218 shs. Raymond James & Assoc invested in 0% or 20,177 shs. Teacher Retirement Sys Of Texas invested 0% of its capital in Endo International plc (NASDAQ:ENDP). Manufacturers Life Insurance The stated it has 322,652 shs. 52,220 were accumulated by Hsbc Public Limited Co. New Jersey-based Prudential Inc has invested 0.05% in Endo International plc (NASDAQ:ENDP). Ameriprise Finance reported 544,596 shs or 0% of all its holdings. Vanguard Group Incorporated reported 0% stake. 291,297 were accumulated by State Board Of Administration Of Florida Retirement. Parametric Port Associates Ltd Co holds 0% of its capital in Endo International plc (NASDAQ:ENDP) for 551,771 shs. California Public Employees Retirement holds 0% of its capital in Endo International plc (NASDAQ:ENDP) for 472,909 shs. Geode Capital Ltd has invested 0% in Endo International plc (NASDAQ:ENDP).

Reiterated Endo International (NASDAQ:ENDP) Rating.

After B. Riley FBR’s $13 PT was revealed to investors on Thursday, 28 June, Endo International (NASDAQ:ENDP) means 34.99 % upside potential.

Endo International plc (NASDAQ:ENDP) Ratings Coverage

In total 11 analysts cover Endo International (NASDAQ:ENDP). “Buy” rating has 3, “Sell” are 0, while 8 are “Hold”. 27% are bullish. 14 are the (NASDAQ:ENDP)’s analyst reports since January 3, 2018 according to StockzIntelligence Inc. The stock rating was downgraded by Mizuho to “Neutral” on Wednesday, April 4. On Wednesday, June 27 the rating was upgraded by Citigroup to “Buy”. On Thursday, June 28 the company was maintained by FBR Capital. On Wednesday, February 28 the rating was downgraded by Gabelli to “Hold”. In Wednesday, February 21 report Canaccord Genuity maintained the stock with “Hold” rating. On Friday, January 19 the rating was maintained by Mizuho with “Buy”. On Wednesday, February 28 William Blair maintained the shares of ENDP in report with “Hold” rating. On Tuesday, February 13 the firm has “Buy” rating by FBR Capital given. On Friday, February 23 the firm earned “Equal-Weight” rating by Barclays Capital. On Monday, March 5 BMO Capital Markets maintained Endo International plc (NASDAQ:ENDP) with “Market Perform” rating.

Ticker’s shares touched $9.63 during the last trading session after 2.03% change.Currently Endo International plc is downtrending after 51.05% change in last June 29, 2017. ENDP has also 3.02M shares volume. ENDP underperformed by 63.62% the S&P 500.

Endo International plc (NASDAQ:ENDP)’s quarterly earnings will be published on August, 14., as reported by Faxor. Analysts expect change of 41.94 % or $0.39 from previous year’s $0.93 earnings per share compared to current’s $0.54 earnings per share. The profit will be $120.84M for ENDP if $0.54 earnings per share becomes true. Wall Street now sees -19.40 % negative EPS growth despite Endo International plc previous quarter’s EPS of $0.67.

Endo International plc, a specialty pharmaceutical company, makes and sells generic and branded pharmaceuticals in the United States, Canada, and internationally.The firm is valued at $2.16 billion. The firm operates through three divisions: U.S.Last it reported negative earnings. Generic Pharmaceuticals, U.S.

For more Endo International plc (NASDAQ:ENDP) news brought out recently go to: Streetinsider.com, Fool.com, Benzinga.com, Profitconfidential.com or Seekingalpha.com. The titles are as follows: “Endo (ENDP) Reports Master Settlement Agreement Allowing for Resolution of Known Testosterone Replacement …” brought out on June 11, 2018, “Why Endo International plc Rocketed Higher Today” on June 06, 2018, “Endo Wins Citi Upgrade On Positive Catalysts, Cellulite Treatment Opportunity” with a publish date: June 27, 2018, “These Indications Suggest That ENDP Stock Has Finally Found a Bottom” and the last “Buy Alibaba – Cramer’s Lightning Round (6/12/18)” with publication date: June 13, 2018.

Endo International plc (NASDAQ:ENDP) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.